Logo

Lucence Diagnostics

Lucence Liquid Biopsy Test to Receive Medicare Reimbursement in Lung Cancer

Lucence's amplicon-based LiquidHallmark liquid biopsy assay will now be covered under a finalized local coverage determination from Medicare contractor Palmetto.

Lucence Taps Omnigen to Distribute Liquid Biopsy Tests in Turkey

The Istanbul-based medical test and device distributor will market Lucence's liquid biopsy tests, including its NGS assay LiquidHallmark, to hospitals and physicians in the region.

Lucence, National Cancer Centre Singapore to Study Liquid Biopsy Assay in Prostate Cancer

The collaborators will evaluate the use of Lucence's LiquidHallmark assay to help make treatment decisions in Asian men with prostate cancer.

Lucence Publishes Clinical Validation of LiquidHallmark Circulating Tumor DNA Test, Expands to RNA
Premium

The firm plans to ramp up US commercialization following the study, while continuing to develop its cell-free RNA diagnostic platform.

New Products Posted to GenomeWeb: Amoy Diagnostics, Akoya Biosciences, Congenica, Lucence

Nov 11, 2021

Lucence, Veterans' Affairs Health Care System Launch Liquid Biopsy Screening Study

Nov 3, 2021

Yemaachi Biotech, Lucence Aim to Improve Genomic Breast Cancer Testing in Ghana and Beyond
Premium

Sep 21, 2021

Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes
Premium

Jun 7, 2021

Lucence Presents New Data on Liquid Biopsy for Late-Stage Cancer Monitoring, Treatment Guidance
Premium

May 11, 2021

Lucence Launches US Validation Study for Liquid Biopsy in Lung Cancer

Mar 24, 2021

Lucence, Waseda University Partner to Develop Laser-Based Liquid Biopsy Platform

Dec 10, 2020

Lucence Obtains CLIA Certification for Palo Alto Lab

May 29, 2020

Lucence Dx Liquid Biopsy Tech Detects Structural Rearrangements, Breast Cancer Mutations
Premium

Jan 27, 2020

Lucence Dx Targets Late-Stage Lung Cancer Monitoring With 2020 US Entry
Premium

Nov 19, 2019

Cancer Diagnostics Firm Lucence Raises $20M

Nov 7, 2019

Lucence Diagnostics, MEDx Partner on Companion Diagnostic Cancer Tests in China

Mar 12, 2019

Lucence Dx, Stanford University Applying AI to Liver Cancer Diagnosis, Treatment

Nov 26, 2018

Lucence Dx Inks India Distribution Deal for Liquid Biopsy Test

Oct 26, 2018

New Products Posted to GenomeWeb: MGI, Lucence Diagnostics, SeraCare, More

Sep 18, 2018

Lucence Diagnostics Names Myanmar Distribution Partner for Cancer Dx Tests

Aug 13, 2018

Lucence Dx Signs Philippine Distribution Deal for Cancer Tests

Breaking News
The Scan

Sick Newborns Selected for WGS With Automated Pipeline

Researchers successfully prioritized infants with potential Mendelian conditions for whole-genome sequencing or rapid whole-genome sequencing, as they report in Genome Medicine.

Acne-Linked Loci Found Through GWAS Meta-Analysis

Researchers in the European Journal of Human Genetics find new and known acne vulgaris risk loci with a genome-wide association study and meta-analysis, highlighting hair follicle- and metabolic disease-related genes.

Retina Cell Loss Reversed by Prime Editing in Mouse Model of Retinitis Pigmentosa

A team from China turns to prime editing to correct a retinitis pigmentosa-causing mutation in the PDE6b gene in a mouse model of the progressive photoreceptor loss condition in the Journal of Experimental Medicine.

CRISPR Screens Reveal Heart Attack-Linked Gene

Researchers in PLOS Genetics have used CRISPR screens to home in on variants associated with coronary artery disease that affect vascular endothelial function.